ESC Premium Access

Tofogliflozin improved pulmonary hypertension due to heart failure with preserved ejection fraction in mice

Presentation

About the speaker

Assistant Professor Yusuke Joki

Juntendo University School of Medicine, Tokyo (Japan)
0 follower

202 more presentations in this session

Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress

Speaker: Doctor T. Yamamoto (Tokyo, JP)

Thumbnail

MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes

Speaker: Doctor C. Lo (Taichung, TW)

Thumbnail

Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense

Speaker: Professor I. Andreadou (Athens, GR)

Thumbnail

Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration

Speaker: Associate Professor G. Rigatelli (Rovigo, IT)

Thumbnail

Melatonin receptor blockade slows ventricular conduction by IK1 downregulation

Speaker: Doctor M. Gonotkov (Syktyvkar, RU)

Thumbnail

Access the full session

Basic science e-posters

Speakers: Assistant Professor Y. Joki, Doctor T. Yamamoto, Doctor C. Lo, Professor I. Andreadou, Associate Professor G. Rigatelli...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis

27 August 2021

ESC Premium Access

Impact of COVID-19 pandemics upon pulmonary hypertension patients: insights from BNP-PL national database

27 August 2021

ESC Premium Access

Heart failure as a complication of covid-19 infection: systematic review and meta-analysis

27 August 2021

This platform is supported by

logo Novo Nordisk